Caricamento...
Use of the VerifyNow point of care assay to assess the pharmacodynamic effects of loading and maintenance dose regimens of prasugrel and ticagrelor
Prasugrel and ticagrelor are potent oral platelet P2Y(12) inhibitors and are recommended over clopidogrel in patients with acute coronary syndrome (ACS). Oral platelet P2Y(12) inhibitors are characterized by varying degrees of pharmacodynamic response profiles as assessed by a variety of commerciall...
Salvato in:
| Pubblicato in: | J Thromb Thrombolysis |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer US
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8049919/ https://ncbi.nlm.nih.gov/pubmed/33582955 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11239-021-02386-7 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|